Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: The Canadian Implantable Defibrillator Study

Circulation

Volumn 101, Issue 14, 2000, Pages 1660-1664

  Sheldon, Robert ^a   Connolly, Stuart ^b   Krahn, Andrew ^c   Roberts, Robin ^b   Gent, Michael ^b   Gardner, Martin ^d  

^a UNIVERSITY OF CALGARY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Arrhythmia; Death; Risk factors; Sudden; Survival; Trials

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FUNCTIONAL ASSESSMENT; HEART VENTRICLE TACHYCARDIA; HUMAN; IMPLANT; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RISK FACTOR; SUDDEN DEATH; SURVIVAL;

EID: 0034636059     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.14.1660     Document Type: Article

References (16)

1. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
2. Connolly SJ, Gent M, Roberts RS, Dorian P, Sheldon R, Mitchell LB, Green M, Klein G, the CIDS investigators. Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter against amiodarone. Circulation. In press.
3. Welch PJ, Page RL, Hamdan MH. Management of ventricular arrhythmias: a trial-based approach. J Am Coll Cardiol. 1999;34:621-630.
4. Mushlin AI, Hall WJ, Zwanzinger J, Gajary E, Andrews M, Marron R, Zou KH, Moss AJ for the MADIT Investigators. The cost-effectiveness of automatic implantable defibrillators: results from MADIT. Circulation. 1998;97:2129-2135.
5. Owens DK, Sanders GD, Harris RA, McDonald KM, Heidenreich PA, Dembitzer AD, Hlatky MA. Cost-effectiveness of implantable cardioverter defibrillators relative to amiodarone for prevention of sudden cardiac death. Ann Intern Med. 1997;126:1-12.
6. Wever EFD, Hauer RNW, Schrijvers G, van Capelle FJL, Tijssen JGP, Crijns HJGM, Algra A, Ramanna H, Bakker PFA, de Medina EOR. Cost-effectiveness of implantable defibrillator as first-choice therapy versus electrophysiologically guided, tiered strategy in postinfarct sudden death survivors: a randomized study. Circulation. 1996;93:489-496.
7. Connolly SJ, Gent M, Roberts R, Dorian P, Green MS, Klein GJ, Mitchell LB, Sheldon RS, Roy D, the CIDS investigators. Canadian Implantable Defibrillator Study (CIDS): study design and organization. Am J Cardiol. 1993;72:103F-108F.
8. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
9. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
10. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34: 187-220.
11. Buyse ME. Analysis of clinical trial outcomes: some comments on subgroup analyses. Control Clin Trials. 1989;10:187S-194S.
12. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation. 1982;65:457-464.
13. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo H. Improved survival with an implanted defibrillator in patients with coronary artery disease at high risk for ventricular arrhythmias. N Engl J Med. 1996;335: 1933-1940.
14. Roy D, Green M, Talajic M, Tang A, Dubuc M, Gardner M, Thibault B, Sami M, Downar E, Kimber S, Roberts R, the CIDS investigators. Mode of death in the Canadian Implantable Defibrillator Study (CIDS). Circulation. 1998;98(suppl I):I-495. Abstract.
15. Krahn AD, Klein GJ, Yee R, Roberts R, the CIDS investigators. The effect of ejection fraction on the relative benefit of the implantable defibrillator in the Canadian Implantable Defibrillator Study (CIDS). Circulation. 1998;98(suppl I):I-468. Abstract.
16. Domanski MJ, Sakseena S, Hallstrom A. Benefit with implantable cardioverter-defibrillators in patients with malignant ventricular arrhythmias and varying degrees of left ventricular dysfunction. Circulation 1998;98(suppl I):I-191. Abstract.